Promising therapeutic approaches in Down Syndrome: addressing parents' doubts-Reference-Cited by-同舟云学术

Promising therapeutic approaches in Down Syndrome: addressing parents' doubts

Published:2024 Issue:1 Volume:21 Page:
ISSN:0973-0966
Container-title:Pediatric Oncall
language:en
Short-container-title:

Author:

Monteiro Sara Alexandra Pinheiro,Soares Sara Maria Marques,Matos Ines Sofia Soares de Azevedo Vaz,Machado Leonilde Augusta Ferreira,Mendes Diana Gonzaga Paulino,Coutinho Ana Catarina de Magalhaes Claro Prior Pereira

Publisher

Pediatric Oncall Pvt Ltd

Subject

General Medicine

Reference31 articles.

1. Delabar JM, Allinquant B, Bianchi D, et al. Changing Paradigms in Down Syndrome: The First International Conference of the Trisomy 21 Research Society. Mol Syndromol. 2016 Oct;7(5):251-261. doi: 10.1159/000449049. Epub 2016 Sep 16. PMID: 27867340; PMCID: PMC5109983.

2. Gardiner KJ. Pharmacological approaches to improving cognitive function in Down syndrome: current status and considerations. Drug Des Devel Ther. 2014 Dec 17;9:103-25. doi: 10.2147/DDDT.S51476. PMID: 25552901; PMCID: PMC4277121.

3. Long R, Drawbaugh ML, Davis CM, et al. Usage of and attitudes about green tea extract and Epigallocathechin-3-gallate (EGCG) as a therapy in individuals with Down syndrome. Complement Ther Med. 2019 Aug;45:234-241. doi: 10.1016/j.ctim.2019.07.002. Epub 2019 Jul 2. PMID: 31331567; PMCID: PMC6929204.

4. Bianchi P, Ciani E, Guidi S, et al. Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for Down syndrome. J Neurosci. 2010 Jun 30;30(26):8769-79. doi: 10.1523/JNEUROSCI.0534-10.2010. PMID: 20592198; PMCID: PMC6632890.

5. Stagni F, Giacomini A, Guidi S, et al. Timing of therapies for Down syndrome: the sooner, the better. Front Behav Neurosci. 2015 Oct 6;9:265. doi: 10.3389/fnbeh.2015.00265. PMID: 26500515; PMCID: PMC4594009.